Skip to main content
SpringerLink
Log in

Is statin discontinuation an option in patients who have had a stroke?

  • Practice Point
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sacco RL and Liao JK (2005) Drug Insight: statins and stroke. Nat Clin Pract Cardiovasc Med 2: 576–584

    Article  CAS  Google Scholar 

  2. Amarenco P et al. (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549–559

    Article  CAS  Google Scholar 

  3. Blanco M et al. (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69: 904–910

    Article  CAS  Google Scholar 

  4. Endres M and Laufs U (2006) Discontinuation of statin treatment in stroke patients. Stroke 37: 2640–2643

    Article  CAS  Google Scholar 

  5. Laufs U et al. (2000) Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102: 3104–3110

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Vascular Medicine Research, Brigham and Women's Hospital, 65 Landsdowne Street, Room 275, Cambridge, MA 02139, USA jliao@rics.bwh.harvard.edu

Authors and Affiliations

  1. JK Liao is the Director of Vascular Medicine Research at the Brigham and Women's Hospital and Associate Professor of Medicine at Harvard Medical School, MA, USA.,

    James K Liao

Authors
  1. James K Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author is a consultant for, and has received speaker honoraria from, AstraZeneca, Boehringer Ingelheim, Merck and Pfizer. He has also received grant/research support from Pfizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liao, J. Is statin discontinuation an option in patients who have had a stroke?. Nat Rev Neurol 4, 18–19 (2008). https://doi.org/10.1038/ncpneuro0687

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0687

  • Springer Nature Limited

Search

Navigation